These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [ Bauman G; Martin P; Thiessen JD; Taylor R; Moussa M; Gaed M; Rachinsky I; Kassam Z; Chin J; Pautler S; Lee TY; Valliant JF; Ward A Eur Urol Focus; 2018 Sep; 4(5):702-706. PubMed ID: 28753797 [TBL] [Abstract][Full Text] [Related]
23. The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy. Gandaglia G; Ploussard G; Valerio M; Mattei A; Fiori C; Roumiguié M; Fossati N; Stabile A; Beauval JB; Malavaud B; Scuderi S; Barletta F; Moschini M; Zamboni S; Rakauskas A; Tian Z; Karakiewicz PI; De Cobelli F; Porpiglia F; Montorsi F; Briganti A Eur Urol; 2020 Jun; 77(6):733-741. PubMed ID: 31547938 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of the prostate bed for local recurrence after radical prostatectomy using endorectal magnetic resonance imaging. Liauw SL; Pitroda SP; Eggener SE; Stadler WM; Pelizzari CA; Vannier MW; Oto A Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):378-84. PubMed ID: 22717242 [TBL] [Abstract][Full Text] [Related]
25. Novel Automated Three-Dimensional Surgical Planning Tool and Magnetic Resonance Imaging/Ultrasound Fusion Technology to Perform Nanoparticle Ablation and Cryoablation of the Prostate for Focal Therapy. Jue JS; Coons S; Hautvast G; Thompson SF; Geraats J; Richstone L; Schwartz MJ; Rastinehad AR J Endourol; 2022 Mar; 36(3):369-372. PubMed ID: 34409850 [No Abstract] [Full Text] [Related]
26. Characteristics of Cancer Progression on Serial Biopsy in Men on Active Surveillance for Early-stage Prostate Cancer: Implications for Focal Therapy. Fasulo V; Cowan JE; Maggi M; Washington SL; Nguyen HG; Shinohara K; Lazzeri M; Casale P; Carroll PR Eur Urol Oncol; 2022 Feb; 5(1):61-69. PubMed ID: 33069628 [TBL] [Abstract][Full Text] [Related]
27. Risk model based on MRI fusion biopsy characteristics predicts biochemical recurrence after radical prostatectomy. Chen Z; Wu J; Sun K; He Y; Zhu Z; Xiao L; Sheng L Prostate; 2022 Apr; 82(5):566-575. PubMed ID: 35067945 [TBL] [Abstract][Full Text] [Related]
28. Preoperative staging using magnetic resonance imaging and risk of positive surgical margins after prostate-cancer surgery. Jäderling F; Akre O; Aly M; Björklund J; Olsson M; Adding C; Öberg M; Blomqvist L; Nyberg T; Wiklund P; Carlsson S Prostate Cancer Prostatic Dis; 2019 Sep; 22(3):391-398. PubMed ID: 30504811 [TBL] [Abstract][Full Text] [Related]
29. MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis. Ahdoot M; Wilbur AR; Reese SE; Lebastchi AH; Mehralivand S; Gomella PT; Bloom J; Gurram S; Siddiqui M; Pinsky P; Parnes H; Linehan WM; Merino M; Choyke PL; Shih JH; Turkbey B; Wood BJ; Pinto PA N Engl J Med; 2020 Mar; 382(10):917-928. PubMed ID: 32130814 [TBL] [Abstract][Full Text] [Related]
30. Persistent Discordance in Grade, Stage, and NCCN Risk Stratification in Men Undergoing Targeted Biopsy and Radical Prostatectomy. Alshak MN; Patel N; Gross MD; Margolis D; Hu JC Urology; 2020 Jan; 135():117-123. PubMed ID: 31568795 [TBL] [Abstract][Full Text] [Related]
31. Spatial Tracking of Targeted Prostate Biopsy Locations: Moving Towards Effective Focal Partial Prostate Gland Ablation with Improved Treatment Planning. Sidelsky S; Setia S; Vourganti S Curr Urol Rep; 2017 Oct; 18(12):93. PubMed ID: 29046984 [TBL] [Abstract][Full Text] [Related]
32. Use of cylindrical coordinates to localize prostate cancers on MRI and prostatectomy pathology. Patel DN; Nguyen C; Sirohi D; Falahatian V; Saouaf R; Luthringer D; Li D; Kim HL Urol Oncol; 2017 Dec; 35(12):673.e15-673.e20. PubMed ID: 28916150 [TBL] [Abstract][Full Text] [Related]
33. Prostate cancer on computed tomography: A direct comparison with multi-parametric magnetic resonance imaging and tissue pathology. Jia JB; Houshyar R; Verma S; Uchio E; Lall C Eur J Radiol; 2016 Jan; 85(1):261-267. PubMed ID: 26526901 [TBL] [Abstract][Full Text] [Related]
34. Comparisons between magnetic resonance/ultrasound fusion-guided biopsy and standard biopsy in the diagnosis of prostate cancer: A prospective cohort study. Zhu G; Wang Q Medicine (Baltimore); 2018 Sep; 97(36):e11962. PubMed ID: 30200076 [TBL] [Abstract][Full Text] [Related]
35. Using spatial tracking with magnetic resonance imaging/ultrasound-guided biopsy to identify unilateral prostate cancer. Zhou SR; Priester AM; Jayadevan R; Johnson DC; Yang JJ; Ballon J; Natarajan S; Marks LS BJU Int; 2020 Mar; 125(3):399-406. PubMed ID: 31680423 [TBL] [Abstract][Full Text] [Related]
36. The Role of Magnetic Resonance Image Guided Prostate Biopsy in Stratifying Men for Risk of Extracapsular Extension at Radical Prostatectomy. Raskolnikov D; George AK; Rais-Bahrami S; Turkbey B; Siddiqui MM; Shakir NA; Okoro C; Rothwax JT; Walton-Diaz A; Sankineni S; Su D; Stamatakis L; Merino MJ; Choyke PL; Wood BJ; Pinto PA J Urol; 2015 Jul; 194(1):105-111. PubMed ID: 25623751 [TBL] [Abstract][Full Text] [Related]
37. The role of perilesional and multiparametric resonance imaging-targeted biopsies to reduce the risk of upgrading at radical prostatectomy pathology: A retrospective monocentric study. Diamand R; Hollans M; Lefebvre Y; Sirtaine N; Limani K; Hawaux E; Abou Zahr R; Mattlet A; Albisinni S; Roumeguère T; Peltier A Urol Oncol; 2022 May; 40(5):192.e11-192.e17. PubMed ID: 35236622 [TBL] [Abstract][Full Text] [Related]
38. Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound-guided prostate biopsy alone: the PROMIS study. Brown LC; Ahmed HU; Faria R; El-Shater Bosaily A; Gabe R; Kaplan RS; Parmar M; Collaco-Moraes Y; Ward K; Hindley RG; Freeman A; Kirkham A; Oldroyd R; Parker C; Bott S; Burns-Cox N; Dudderidge T; Ghei M; Henderson A; Persad R; Rosario DJ; Shergill I; Winkler M; Soares M; Spackman E; Sculpher M; Emberton M Health Technol Assess; 2018 Jul; 22(39):1-176. PubMed ID: 30040065 [TBL] [Abstract][Full Text] [Related]
39. Salvage open radical prostatectomy for recurrent prostate cancer following MRI-guided transurethral ultrasound ablation (TULSA) of the prostate: feasibility and efficacy. Nair SM; Stern N; Dewar M; Siddiqui K; Smith E; Gomez JA; Moussa M; Chin JL Scand J Urol; 2020 Jun; 54(3):215-219. PubMed ID: 32308085 [No Abstract] [Full Text] [Related]
40. Prostate MRSI predicts outcome in radical prostatectomy patients. Zakian KL; Hatfield W; Aras O; Cao K; Yakar D; Goldman DA; Moskowitz CS; Shukla-Dave A; Tehrani YM; Fine S; Eastham J; Hricak H Magn Reson Imaging; 2016 Jun; 34(5):674-81. PubMed ID: 26821278 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]